AXNA.F Amplifon S.p.A

Healthcare Health Care Providers & Services Frankfurt Exchange
12.10 EUR
Close of Nov 11, 2026
7.59 13.81
Market cap
EUR 3.22B
P/E
39.0x
P/B
2.09x
ROE
5.1%
Dividend yield
2.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is AXNA.F undervalued?

Graham number
Price12.10
Graham value6.35
Premium90.5%

AXNA.F trades 90.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amplifon S.p.A fundamental analysis

No fundamental analysis for Amplifon S.p.A yet.

Amplifon S.p.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amplifon S.p.A

Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 19…

Full company profile